Alexander B Sibley

10PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Yingmiao Liu, Jiatong Li, Jing Lyu

|Dec 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).

Andrew B Nixon, Alexander B Sibley, Yingmiao Liu

|Dec 02, 2021
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.

Julia C F Quintanilha, Jin Wang, Alexander B Sibley

|Oct 07, 2021
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.

Julia C F Quintanilha, Jin Wang, Alexander B Sibley

|May 26, 2021
Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.

Chang-Lung Lee, Kennedy D Brock, Stephanie Hasapis

|Oct 07, 2020
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence.

Andrea Walens, Jiaxing Lin, Jeffrey S Damrauer

Pageof 2

Frequent Collaborators

3 joint publications

Herbert I Hurwitz

3 joint publications

Andrew B Nixon

2 joint publications

James T Auman

2 joint publications

Kirsten Bell Burdett